Chemical synthesis of mouse cripto CFC variants

Proteins: Structure, Function and Genetics

Volumn 64, Issue 3, 2006, Pages 779-788

  Marasco, Daniela ^a   Saporito, Angela ^a   Ponticelli, Salvatore ^b   Chambery, Angela ^c   De Falco, Sandro ^b   Pedone, Carlo ^a   Minchiotti, Gabriella ^a,b   Ruvo, Menotti ^a  

^a CNR   (Italy)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

CD spectroscopy; Domain refolding; Enzyme digestion; Peptide synthesis; Receptor binding

Indexed keywords

GROWTH FACTOR; PROTEIN CRIPTO; UNCLASSIFIED DRUG;

ARTICLE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SYNTHESIS; RECEPTOR BINDING;

ACTIVIN RECEPTORS, TYPE I; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CHROMATOGRAPHY, LIQUID; CIRCULAR DICHROISM; EPIDERMAL GROWTH FACTOR; KINETICS; MASS SPECTROMETRY; MEMBRANE GLYCOPROTEINS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; PEPTIDES; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 33746268430     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.21043     Document Type: Article

References (41)

1. Dono R, Scalera L, Pacifico F, Acampora D, Persico MG, Simeone A. The murine cripto gene: expression during mesoderm induction and early heart morphogenesis. Development 1993;118:1157-1168.
2. Adamson ED, Minchiotti G, Salomon DS. Cripto: a tumor growth factor and more. J Cell Biol 2002;190:267-278.
3. Bianco C, Normanno N, Salomon DS, Ciardiello F. Role of the cripto (EGF-CFC) family in embryogenesis and cancer. Growth Factors 2004;22:133-139.
4. Minchiotti G. Nodal-dependent Cripto signaling in ES cells: from stem cells to tumor biology. Oncogene 2005;24:5668-5675.
5. Wechselberger C, Strizzi L, Kenney N, et al. Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma. Oncogene 2005; 24:4094-4105.
6. Minchiotti G, Parisi S, Liguori G, et al. Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development. Mech Dev 2000;90:133-142.
7. Lohmeyer M, Harrison PM, Kannan S, et al. Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto. Biochemistry 1997;36: 3837-3845.
8. Salomon DS, Bianco C, Ebert AD, et al. The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. Endocr Relat Cancer 2000;7:199-226.
9. Foley SF, van Vlijmen HW, Boynton RE, et al. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis. Eur J Biochem 2003;270:3610-3618.
10. Minchiotti G, Manco G, Parisi S, Lago CT, Rosa F, Persico MG. Structure-function analysis of the EGF-CFC family member Cripto identifies residues essential for nodal signalling. Development 2001;128:4501-4510.
11. Yeo CY, Whitman M. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms. Mol Cell 2001;7: 949-957.
12. Yan Y, Liu J, Luo YEC, Haltiwanger RS, Abate-Shen C, Shen MM. Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway. Mol Cell Biol 2002;22:4439-4449.
13. Shen MM, Schier AF. The EGF-CFC gene family in vertebrate development. Trends Genet 2000;16:303-309.
14. Whitman M. Nodal signaling in early vertebrate embryos. Themes and variations. Dev Cell 2001;1:605-617.
15. Parisi S, D'Andrea D, Lago CT, Adamson ED, Persico MG, Minchiotti G. Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells. J Cell Biol 2003;163:303-314.
16. Salomon DS, Bianco C, De Santis M. Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia. Bioessays 1999;21:61-70.
17. Bianco C, Strizzi L, Ebert A, et al. Role of human cripto-1 in tumor angiogenesis. J Natl Cancer Inst 2005;97:132-141.
18. Xing PX, Hu XF, Pietersz GA, Hosick HL, McKenzie IFC. Cripto: a novel target for antibody-based cancer immunotherapy. Cancer Res 2004;64:4018-4023.
19. Ciardiello F, Kim N, Saeki T, et al. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci USA 1991;88:7792-7796.
20. Herrington EE, Ram TG, Salomon DS. Expression of epidermal growth factor-related proteins in the aged adult mouse mammary gland and their relationship to tumorigenesis. J Cell Physiol 1997;170:47-56.
21. De Luca A, Casamassimi A, Selvam MP, et al. EGF-related peptides are involved in the proliferation and survival of MDA-MB-468 human breast carcinoma cells. Int J Cancer 1999;80:589-594.
22. Kenney NJ, Smith GH, Maroulakou IG, et al. Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice. Mol Carcinog 1996;15:44-56.
23. Wechselberger C, Strizzi L, Kenney N, et al. Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma. Oncogene 2005; 24:4094-4105.
24. Adkins HB, Bianco C, Schiffer SG, et al. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J Clin Invest 2003;112:575-587.
25. Gray PC, Harrison CA, Vale W. Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc Natl Acad Sci USA 2003;100:5193-5198.
26. Persico MG, Liguori GL, Parisi S, D'Andrea D, Salomon DS, Minchiotti G. Cripto in tumors and embryo development. Biochim Biophys Acta 2001;1552:87-93.
27. Bianco C, Normanno N, Salomon DS, Ciardiello F. Role of the cripto (EGF-CFC) family in embryogenesis and cancer. Growth Factors 2004;22:133-139.
28. Song J, Oh SP, Schrewe H, et al. The type II activin receptors are essential for egg cylinder growth, gastrulation, and rostral head development in mice. Dev Biol 1999;213:157-169.
29. Bianco C, Adkins HB, Wechselberger C, et al. Cripto-1 activates nodal- and ALK4-dependent and independent signaling pathways in mammary epithelial cells. Mol Cell Biol 2002;22:2586-2597.
30. Schier AF, Shen MM. Nodal signalling in vertebrate development. Nature 2000;403:385-389.
31. Schiffer SG, Foley S, Kaffashan A, et al. Fucosylation of Cripto is required for its ability to facilitate nodal signaling. J Biol Chem 2001;276:37769-37778.
32. Barcellos-Hoff MH, Ewan KB. Transforming growth factor-beta and breast cancer: mammary gland development. Breast Cancer Res 2000;2:92-99.
33. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117-129.
34. Risbridger GP, Schmitt JF, Robertson DM. Activins and inhibins in endocrine and other tumors. Endocr Rev 2001;22:836-858.
35. Wakefield LM, Roberts AB. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 2002;12: 22-29.
36. Harrison CA, Gray PC, Vale WW, Robertson DM. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 2005;16:73-78.
37. Cheng SK, Olale F, Bennett JT, Brivanlou AH, Schier AF. EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1. Gene Dev 2003;17:31-36.
38. Johnson WC Jr. Protein secondary structure and circular dichroism: a practical guide. Proteins 1990;7:205-214.
39. Fields GB, Noble RL. Solid phase peptide synthesis utilizing 9-fluorenylmethoxy-carbonil amino acids. Int J Pept Protein Res 1990;35:161-214.
40. Tam JP, Wu CR, Liu W, Zhang JW. Bisulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications. J Am Chem Soc 1991;113:6657-6662.
41. Moroney JV, Fullmer CS, McCarty RE. Characterization of the cysteinyl-containing peptides of the gamma subunit of coupling factor 1. J Biol Chem 1984;259:7281-7285.